Before the Bell Scans: Hologic Inc., St. Jude Medical Inc., ResMed Inc., and
Navidea Biopharmaceuticals Inc.
Editor Note: For more information about this release, please scroll to bottom.
LONDON, August 30, 2013
LONDON, August 30, 2013 /PRNewswire/ --
The U.S. equity market advanced on Thursday, August 29, 2013. All three
benchmark indexes edged higher, with the Dow Jones Industrial Average gaining
0.11%, S&P 500 gaining 0.20%, and the NASDAQ Composite advancing 0.75%. Shares
in the medical appliances and equipment companies ended on a mixed note as the
broader market edged higher. The major movers in the sector included Hologic
Inc. (NASDAQ: HOLX), St. Jude Medical Inc. (NYSE: STJ), ResMed Inc. (NYSE:
RMD), and Navidea Biopharmaceuticals Inc. (NYSE MKT: NAVB). All these
companies are tracked by AAAResearchReports.com. Free technical research on
HOLX, STJ, RMD, and NAVB can be downloaded upon sign up at:
On Thursday, Hologic Inc.'s stock closed 0.60% lower at $21.57 after
oscillating between $21.39 and $21.72. A total of 1.85 million shares were
traded, which is less than its daily average volume of 3.26 million. The
company's stock has gained 6.94% in last three months, outperforming the S&P
500 which has lost 0.62% during the same period. Moreover, the company's
shares are trading above their 50-day and 200-day moving averages. Sign up
today to read free research report on HOLX at:
Shares in St. Jude Medical Inc. fluctuated between gains and losses on
Thursday before closing the day nearly flat. The company's shares traded
between $50.12 and $50.93 before ending the day 0.02% lower at $50.60. A total
of 0.63 million shares traded, which is below the daily average volume of 1.84
million. The company's stock has gained 14.43% in the last three months,
outperforming the S&P 500 which has fallen by 0.62% during the same period.
Additionally, St. Jude Medical Inc.'s stock is trading above its 50-day and
200-day moving averages. Register to download free technical analysis on STJ
ResMed Inc.'s shares posted modest gains on Thursday. The company's shares
traded between $47.92 and $48.46 before finishing the day 0.06% higher at
$48.23. A total of 0.66 million shares were traded, which is below the daily
average volume of 1.09 million. The company's shares have gained 4.51% in the
last one month, outperforming the S&P 500 which has lost 2.80% during the same
period. Furthermore, ResMed Inc.'s stock is currently trading above its 50-day
and 200-day moving averages. A free report on RMD can be accessed by
Shares in Navidea Biopharmaceuticals Inc. moved higher on Thursday, extending
their gains from previous trading sessions. The company's shares ended the day
at $2.99, up 1.01%, after oscillating between $2.91 and $3.01. A total of 0.29
million shares were traded, which is below the daily average volume of 0.68
million. The company's stock is up 26.16% in the last three months,
outperforming the S&P 500 which has lost 0.62% during the same period.
Additionally, Navidea Biopharmaceuticals Inc.'s stock is trading above its
50-day and 200-day moving averages. Register with AAA Research Reports and
download the research on NAVB for free at:
1.This is not company news. We are an independent source and our views do
not reflect the companies mentioned.
2.Information in this release is fact checked and produced on a best efforts
basis and reviewed by a CFA ® charterholder. However, we are only human
and are prone to make mistakes. If you notice any errors or omissions,
please notify us below.
3.This information is submitted as a net-positive to companies mentioned, to
increase awareness for mentioned companies to our subscriber base and the
4.If you wish to have your company covered in more detail by our team, or
wish to learn more about our services, please contact us at
5.For any urgent concerns or inquiries, please contact us at
6.Are you a public company? Would you like to see similar coverage on your
company? Send us a full investors' package to
research@EquityNewsNetwork.com for consideration.
Content is researched, written and reviewed on a best-effort basis. This
document, article or report is prepared and authored by Equity News Network.
An outsourced research services provider has, through Chartered Financial
Analysts, only reviewed the information provided by Equity News Network in
this article or report according to the Procedures outlined by Equity News
Network. Equity News Network is not entitled to veto or interfere in the
application of such procedures by the outsourced provider to the articles,
documents or reports, as the case may be.
NOT FINANCIAL ADVICE
Equity News Network makes no warranty, expressed or implied, as to the
accuracy or completeness or fitness for a purpose (investment or otherwise),
of the information provided in this document. This information is not to be
construed as personal financial advice. Readers are encouraged to consult
their personal financial advisor before making any decisions to buy, sell or
hold any securities mentioned herein.
NO WARRANTY OR LIABILITY ASSUMED
Equity News Network is not responsible for any error which may be occasioned
at the time of printing of this document or any error, mistake or shortcoming.
No liability is accepted by Equity News Network whatsoever for any direct,
indirect or consequential loss arising from the use of this document. Equity
News Network expressly disclaims any fiduciary responsibility or liability for
any consequences, financial or otherwise arising from any reliance placed on
the information in this document. Equity News Network does not (1) guarantee
the accuracy, timeliness, completeness or correct sequencing of the
information, or (2) warrant any results from use of the information. The
included information is subject to change without notice.
SOURCE AAA Research Reports
Contact: Peter F. Jones, Phone #: +1(646)396-9126, Email ID:
Press spacebar to pause and continue. Press esc to stop.